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Kabell S, Handberg KJ, Li Y, Kusk M, Bisgaard M: Detection of vvIBDV in vacci-
nated SPF chickens. Acta vet. scand. 2005, 46, 219-227. – The purpose of our exper-
iment was to investigate, if apparently healthy, vaccinated chickens may be involved in
maintaining and spreading infectious bursal disease virus (IBDV) in poultry environ-
ments. We aimed at simultaneous detection and identiﬁcation of very virulent ﬁeld
strain IBDV (vvIBDV) as well as vaccine strain IBDV in experimentally infected chick-
ens. Two groups of speciﬁc pathogen free (SPF) chickens were vaccinated using the in-
termediate infectious bursal disease (IBD) vaccine D78. Group 1 was vaccinated at the
age of one week and group 2 at the age of three weeks. Both groups were challenged
with vvIBDV at the age of four weeks. A third, vaccinated, non-challenged group served
as negative control. No clinical symptoms were observed in any of these groups. The
chickens were euthanised and submitted to autopsy and sample preparation in groups of
three at ﬁxed intervals from the age of 28 to 44 days. Gross pathological lesions were
not observed. Lymphoid tissues from the bursa of Fabricius, bone marrow, spleen and
thymus in addition to cloacal- and bursal swaps were analysed by one-step reverse tran-
scription polymerase chain reaction (RT-PCR). Positive results were conﬁrmed by two-
step strain speciﬁc duplex (DPX) RT-PCR. The vaccine strain was detected in bursa tis-
sues from all groups, while the challenge strain was detected in few bursal as well as
non-bursal tissue samples. 
The results indicate a possibility of replication of vvIBDV in vaccinated chickens.
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Acta vet. scand. 2005, 46, 219-227.
Acta vet. scand. vol. 46 no. 4, 2005
Detection of vvIBDV in Vaccinated SPF Chickens
By S. Kabell1, K. J. Handberg1, Y. Li1, M. Kusk1 and M. Bisgaard2
1Danish Institute for Food and Veterinary Research, Hangøvej 2, DK-8200 Aarhus N. 2Department of Veterinary
Pathobiology, The Royal Veterinary and Agricultural University, 4 Stigbøjlen, DK-1870 Frederiksberg C, Den-
mark.
Introduction 
Gumboro disease or infectious bursal disease
(IBD) is associated with reduced production
parameters, increased mortality and immuno-
suppression in young chickens (Jorgensen et al.
1995; Lasher & Davis 1997; Saif 1998). The
etiological agent, infectious bursal disease
virus (IBDV) is a small and very stable RNA-
virus that may survive even thorough cleaning
and disinfection of poultry houses (Chettle et
al. 1989). Two serotypes, serotypes 1 and 2 are
recognised (McFerran et al. 1980), of which
only serotype 1 is pathogenic to the domesti-
cated chicken. Extensive virus replication takes
place in the bursa of Fabricius of the infected
chicken, resulting in lesions in the bursa tissue
and viremia followed by damage of other lym-
phoid organs: spleen, bone marrow, thymus and
germinal centres of caecal tonsils (Cheville
1967). Lesions found in non-bursal lymphoid
tissues are usually less pronounced compared
to lesions in the bursa (Ley et al. 1983). The
severity of the infection depends on the virus
strain and on the susceptibility of the host, re-
garding age (Allan et al. 1972), breed (Nielsen
et al. 1998) and antibody level (van den Berg
1991). The most virulent IBDV strains cause
severe but unspeciﬁc clinical symptoms includ-
ing anorexia, depression, diarrhoea and high
mortality rates three to six days after infection
in three to six weeks old, susceptible chickens.The disease is mainly controlled by vaccination
(van den Berg 2000, Muller et al. 2003). Most
of the Danish commercial breeders are vacci-
nated and serologically tested to ensure high
and uniform levels of maternally derived anti-
bodies (MDA) in their offspring. MDA and
high biosecurity levels in all parts of the pro-
duction intentionally prevent introduction and
spread of diseases, including IBD. However,
clinical outbreaks of IBD, deﬁned as reported
cases with typical clinical signs, increased mor-
tality and pathological lesions including one or
more chicken ﬂocks in the same farm were re-
ported from 1998 (Flensburg 2001) until 2003,
interrupted by a 14 months break including
2001. Based upon previous experiences, vacci-
nation of broilers in and around affected farms
was recommended for up to three broods suc-
ceeding an outbreak. The vaccine strains were
live, intermediate, attenuated IBDV strains.
From March 2002 to February 2003, a total of
43 cases of clinical outbreaks of IBD were re-
ported, involving approximately 10% of broiler
producing farms in Denmark. Approximately
one third of the ﬂocks involved in these out-
breaks had been vaccinated, 60% twice and
40% once, giving rise to questions concerning
presence of virulent ﬁeld virus in vaccinated
ﬂocks. For this reason, our experiment was
aimed at investigating, if vaccinated chickens
could contain virulent virus.
High levels of maternally derived antibodies
(MDAs) inhibit an active immune response to-
wards vaccination (Lucio & Hitchner 1979;
Naqi et al. 1983). The level of antibody that a
vaccine can break through depends on the vac-
cine strain (Winterﬁeld et al. 1980). Mild vac-
cine strains are efﬁcient only when chickens
have no or very low levels of MDA, while the
intermediate strains including D78, and the
"hot" strains can break through higher levels of
MDA titres (van den Berg et al. 1991). Chick-
ens from more than one parent ﬂock may be
mixed in the same broiler house, adding to the
variation in the level of MDA. Even anticipat-
ing optimal timing of a single vaccination, op-
timal vaccine quality and optimal handling of
vaccines, some chickens in the ﬂock may not
respond optimally to the vaccination due to
MDA. Consequently, broiler farmers are often
advised to vaccinate a ﬂock twice. The ﬁrst vac-
cination is carried out early to beneﬁt chickens
with the lowest levels of MDA, while the sec-
ond vaccination is carried out at a later age,
when the highest initial levels of MDA have
waned, often at the age of three weeks. Groups
1 and 2 in the present experiment represent
early and late vaccination respectively. Consid-
ering that SPF chickens have no MDA against
IBDV, we vaccinated group 1 at seven days, the
earliest vaccination time recommended, to al-
low ample time for antibody production prior to
challenge with ﬁeld virus. Group 2 was only al-
lowed one week to develop immunity before
challenge, relying on the chickens' ability to
produce virus-neutralizing antibodies three to
four days post infection (Skeeles et al. 1979).
This group had the advantage of a more mature
age as to immuno competence (Mast and God-
deeris 1999) before vaccination.
The objective of the present study was detection
of virulent IBDV in lymphoid tissues and swab
samples from vaccinated chickens indicating
virus replication and excretion respectively. We
used a commercial RT-PCR assay for detection
of virus RNA, succeeded by a modiﬁcation of a
strain-speciﬁc RT-PCR assay recently devel-
oped at our laboratory (Kusk et al. 2005). 
Materials and methods
Chickens
Fertile eggs from IBDV antibody-free SPF hens
from Lohmann Tierzucht (Cuxhaven, Germa-
ny) were hatched in a controlled environment
under laboratory conditions. The chickens were
raised in isolators with ﬁltered air-ﬂow (HM
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vided with unlimited access to water and a
commercial chicken feed. A light programme
ensured 18 hours of daylight interrupted by six
hours of darkness after the age of one week. 
IBDV strains and inoculation protocol
The vaccine strain Nobilis® Gumboro D78 Vet
(Intervet International B.V. Boxmeer, The
Netherlands) (D78) with a titre of 105
ELD50/ml was used according to the manufac-
turer's instructions; one dose was given orally
to each chicken by syringe. A vvIBDV strain
isolated from a Danish outbreak in 1998
(Handberg et al. 2001), Gen Bank Accession
No. AY850693 (DK01) was extracted from
bursa tissues of previously infected chickens.
The bursa tissues were homogenised in a mor-
tar using a pestle and sterile sand. The ho-
mogenate was suspended in 10% phosphate
buffered saline (PBS) containing 10,000 U/ml
penicillin, 10,000 µg/ml streptomycin, 250
µg/ml gentamycin, 500 U/ml nystatin and 5%
FBS (Invitrogen). After centrifugation for 15
minutes at 3000 rpm, the supernatant was col-
lected and diluted in Hank's buffered saline
solution (HBSS) (GibcoTM, Scotland) to 10-1,
10-2, 10-3, 10-4, 10-5 and inoculated on the
chorio-allantoic membrane (CAM) of embry-
onated hen's eggs to determine virus titres
(Busby et al. 1964). The titre value was 104.2
ELD50/ml. After a 1,000 fold dilution in
HBSS, 0.2 ml per chicken was inoculated as
drops in the eyes, nostrils and beak.
Experimental design
Twenty-four chickens from group 1 were inoc-
ulated with D78 at the age of seven days, and 24
chickens from group 2 were similarly inocu-
lated with D78 at the age of 21 days. Both
groups were challenged with DK01 at the age
of 28 days. A group of nine chickens vaccinated
at the age of 21 days and not challenged served
as negative control. All three groups were ob-
served twice daily for clinical symptoms. The
chickens in groups 1 and 2 were bled and eu-
thanised three at a time at the ages of 28, 29, 30,
31, 36, 38, 42 and 44 days. These chickens were
numbered 1 to 24 in both groups. Chickens in
the negative control group were sampled only
on days 21, 30 and 38 and numbered 1 to 9. Eu-
thanisation was performed in accordance with
Article 2 (1) in Directive 86/609/EEC of 24
November 1986. Necropsy was performed im-
mediately after euthanisation. Tissue samples
from the bursa of Fabricius, bone marrow,
spleen and thymus were removed and frozen at
-80°C. Cloacal swabs were collected and frozen
at -80°C. As RT-PCR results of cloacal swabs
from group 1 and the negative control group
turned out to be inconsistent (not shown), we
decided to collect bursa swabs in addition to
cloacal swabs from group 2. 
In order to estimate the analytical sensitivity of
the two RT-PCR assays, the assays were applied
to 0, 10, 100, 1,000 and 10,000 fold dilutions of
RNA extractions from each of the virus strains
D78 and DK01. Qiagen RT-PCR could detect
RNA from D78 in 0, 10 and 100 fold dilutions,
and from DK01 in 0, 10, 100 and 1,000 fold di-
lutions, whereas DPX RT-PCR could detect
RNA from D78 in 0 and 10 fold dilutions and
from DK01 in 0, 10 and 100 fold dilutions. As
the results indicated that apparently the Qiagen
RT-PCR performed with better sensitivity than
the DPX RT-PCR, the Qiagen RT-PCR was
used for the initial analyses. In case of at least
one positive result within one type of samples,
all similar samples from the same group of
chickens were subjected to duplex (DPX) RT-
PCR analysis to allow conﬁrmation of the virus
strain(s) involved. 
Serology
Agar gel immunodiffusion (AGID) was used
for serum samples from all chickens, per-
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Extraction of RNA
Frozen tissues were homogenized and sus-
pended as previously described. Each swab
sample was shaken in 2 ml of the previously de-
scribed PBS solution for one hour before the
swab was discarded. The suspensions were cen-
trifuged for 15 minutes at 3000 rpm. RNA was
extracted from the supernatants using Qiagen
Rneasy® Mini Kit (Qiagen GmbH, Hilden,
Germany). The protocol was modiﬁed as fol-
lows: initially 400 µl of sample supernatant was
mixed with 300 µl of lysis buffer containing 6 µl
ß-mercapto ethanol (Sigma-Aldrich Co., Ger-
many). This mixture was incubated at room
temperature for one hour. From this point on the
manufacturer's instructions were followed.
Qiagen RT-PCR
The QIAGEN OneStep RT-PCR Kit (Qiagen
GmbH, Hilden, Germany) was used according
to the manufacturer's instructions. Brieﬂy, 10 µl
of a 5 × reaction buffer, 2 µl dNTP mix, 2 µl en-
zyme mixture, 100 pmol of each oligonucleo-
tide and 5 µl of RNA were mixed with RNase-
free water to a ﬁnal volume of 50 µl. All
ingredients were kept on ice during handling. 
The PCR reaction was performed in a Biometra
T3 Thermocycler (Biometra GmbH, Germany)
as follows: 30 minutes at 50°C (RT reaction);
94°C for 15 minutes (initial PCR activation); 39
three-step cycles of 94°C for 30 sec, 58°C for 1
minute and 68°C for 2 minutes; 68°C for 7 min-
utes (ﬁnal extension).
Reverse transcription (RT) reaction
The iScriptTMcDNA Synthesis Kit (BioRad
Laboratories, Hercules, USA) was used accord-
ing to the manufacturer's instructions. Brieﬂy, 5
µl of RNA extraction was mixed with 1 µM of
RT primers (Kusk et al. 2005), denatured for
ﬁve minutes at 94°C, chilled on ice, annealed at
55°C for ﬁve minutes and chilled on ice. Four-
teen µl of RT mixture containing 1 × RT buffer
with 4 units of iScript Reverse Transcriptase
were added, and after ﬁve minutes at room tem-
perature the RNA samples were reverse tran-
scribed for 30 minutes at 42°C, inactivated at
85°C for 5 minutes and stored at -20°C. 
Duplex RT-PCR
Duplex RT-PCR (DPX RT-PCR) represents a
modiﬁcation of the use of primers in the multi-
plex RT- PCR (iScript) previously described by
Kusk et al. (2005). The primers included in the
PCR mixture were only the four speciﬁc
primers for D78 and DK01, D78-fp776, D78-
rp955, DK01-fp775, DK01-rp1028, and the
concentration was increased to 1µM of each
primer.
Results
Clinical, pathological and serological results
No clinical symptoms were observed in any
chicken involved in the experiment. Gross
pathological lesions were not observed during
the experiment. Serological analyses showed
that all the chickens had seroconverted the ﬁrst
time blood was collected after vaccination (data
not shown). 
Qiagen RT-PCR
RNA from IBDV was detected in 14 of 24 bursa
tissue samples and one bone marrow sample in
group 1. In group 2, 19 of 24 bursa tissue sam-
ples, two bone marrow samples, a thymus sam-
ple and four bursa swab samples showed posi-
tive results. In the negative control group, bursa
tissue sample results were positive in three of
six chickens. Negative results were obtained
from thymus- and spleen tissues from group 1,
spleen tissues from group 2, and spleen-, bone
marrow- and thymus tissues from the negative
control group (data not shown). The initial ana-
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sitivity using the Qiagen RT-PCR assay than the
DPX RT-PCR assay. Consequently, series of
samples showing negative results when sub-
jected to Qiagen RT-PCR were regarded as be-
ing truly negative and exempted from further
analyses. As RT-PCR results of cloacal swab
analyses were inconsistent after the samples
had been stored, all these results were excluded. 
DPX RT-PCR
RNA from D78 was detected in bursa tissue
samples from 10 of the 24 chickens in group 1
at the ages of 28, 29, 30, 31 and 38 days, and in
a bone marrow sample from a 42 days old
chicken. RNA from the challenge virus DK01
was not detected in bursa tissues from this
group, but in a single bone marrow sample
from a 44 days old chicken (Table 1). In group
2, RNA from D78 was found in all bursa tissue
samples with one exception from day 42, while
RNA from DK01 was detected in three chick-
ens at the ages of 29, 31 and 44 days, respec-
tively, as shown in Fig. 1 and Table 1. Analyses
of non-bursal samples from group 2 revealed
RNA from D78 in two bone marrow samples at
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Table 1. DPX RT-PCR results of lymphoid tissue analyses from groups 1, 2 and the negative control group
(Ctr), vaccinated at one, three and three week of age, respectively, and challenged with ﬁeld virus at four weeks.
The chickens were sampled in groups of three.
Age in Days Chicken RT-PCR RT-PCR RT-PCR RT-PCR
days after Group No. Bursa of Bone Thymus Bursa
challenge Fabricius marrow swabs
28 0 1 1,2,3 A A A 0 0 0 0 0 0 ND
- 2 1,2,3 A A A A 0 0 0 0 0 0 A A
29 1 1 4,5,6 A 0 0 0 0 0 0 0 0 ND
- 2 4,5,6 A AB A 0 0 0 0 0 0 A A 0
30 Ctr 4,5,6 A A A 0 0 0 0 0 0 ND
2 1 7,8,9 A A 0 0 0 0 0 0 0 ND
- 2 7,8,9 A A A 0 0 0 0 0 0 0 A 0
31 3 1 10,11,12 A A A 0 0 0 0 0 0 ND
- 2 10,11,12 A A AB 0 0 0 0 0 B 0 0 B
36 8 1 13,14,15 0 0 0 0 0 0 0 0 0 ND
- 2 13,14,15 A A A 0 0 A 0 0 0 0 0 0
38 Ctr. 7,8,9 0 0 A 0 0 0 0 0 0 ND
10 1 16,17,18 0 0 A 0 0 0 0 0 0 ND
- 2 16,17,18 A A A 0 0 0 0 0 0 0 0 0
42 14 1 19,20,21 0 0 0 0 A 0 0 0 0 ND
- 2 19,20,21 A 0 A 0 0 0 0 0 0 A 0 0
44 16 1 22,23,24 0 0 0 B 0 0 0 0 0 ND
- 2 22,23,24 A A AB 0 0 0 0 0 0 0 0 0
0: negative result, A: RNA from vaccine strain D78 B: RNA from vvIBDV DK01 
ND: not donethe ages of 28 and 36 days, respectively. DK01
was identiﬁed in a single thymus sample of a 31
days old chicken. In the bursal swab samples,
RNA from D78 was detected in six chickens at
the ages of 28, 29, 30 and 42 days. The chal-
lenge strain was detected in a single bursal
swab sample from a 31 days old chicken. 
In the negative control group, RNA from D78
was identiﬁed in four of six bursas sampled at
the ages of 30 and 38 days. 
Discussion
Clinical outbreaks of IBD in vaccinated broiler
ﬂocks have caused concern in the Danish poul-
try industry. The reasons for these outbreaks
could be high levels of MDA at the time of vac-
cination that would block responses towards the
vaccine, or it could be improper practical han-
dling of the vaccine, decreasing its effect or dis-
tribution, or new antigenic variant strains could
be emerging. While these factors are most often
investigated in connection with each outbreak,
a potential reversion of the vaccine strain to vir-
ulence or survival of virulent strains in vacci-
nated chickens remains to be investigated.
Continuous vaccinations contain a risk that vac-
cine strains may survive in the environment and
regain virulence after passage in chickens (Ya-
maguchi et al. 2000). As vaccination of broilers
has not been routinely used in Denmark, we
speculated that in our case it was more likely,
that surviving ﬁeld virus might infect, replicate
and persist in vaccinated chickens.
Serum samples from the experimental chick-
ens documented seroconversion before chal-
lenge, and as might be anticipated from previ-
ous studies, vaccine virus was detected in most
bursa samples, contrary to the other lymphoid
tissues (Kabell et al. 2005). The detection of
vaccine virus in bursa swabs from group 2 is
concordant with the bursa tissue results and
could be interpreted as excretion of virus. One
bone marrow sample from group 1 and two
from group 2 contained vaccine virus RNA,
which cannot be explained by a mechanism
connected to the challenge, as one sample was
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Figure 1. DPX RT-PCR results of bursa tissues from group 2, samples No. 5, 12 and 24. Two fragments hav-
ing a length of 179 and 253 base pairs respectively, corresponding to D78 and DK01 are visible.positive before inoculation with DK01. How-
ever, vaccine strain IBDV has been detected in
non-bursal lymphoid organs before (Barlic-
Maganja et al. 2002), and even though virus
strain and lymphoid tissues were different, a
difference in sensitivity between the MPX and
DPX RT-PCR assays might explain this diver-
gence with previous results (Kabell et al.2005). 
The load of D78 seemed less in group 1 than in
group 2, probably illustrating that the vaccine
strain gradually disappears from the tissues
with time (Table 1). In the negative control
group, vaccine virus seemed to be disappearing
earlier than in the similarly vaccinated group 2,
but the number of samples is too small for fur-
ther interpretations. The virulent strain DK01
was detected in bursa tissues from three chick-
ens from group 2, one of which also contained
DK01 in thymus tissue and the bursal swab.
Presence of DK01 in the bursa and thymus
from group 2 and in a bone marrow sample
from group 1 indicates virus replication in the
vaccinated chickens in spite of successful vac-
cination. 
The number of chickens found positive for
DK01 was small, however the number of exper-
imental chickens was also of limited size. Our
observations do not exclude that surviving ﬁeld
virus in a broiler house may infect, replicate
and be excreted from vaccinated chickens. An
observation on the same aspect but regarding
Newcastle disease virus (Alexander et al. 1999)
concluded that vaccination does not prevent
replication and excretion of challenge virus.
Assuming that viable IBDV may be excreted
under predisposing conditions including sus-
ceptible chickens, the ﬁnal result may be a dis-
ease outbreak.
Less ﬁeld virus replication was observed in
chickens challenged three weeks after vaccina-
tion compared with chickens challenged one
week after vaccination, adding to the general
recommendations of protecting vaccinated
chickens from ﬁeld virus as long as possible, al-
lowing time for development of an optimal im-
mune response. 
In conclusion, the simultaneous identiﬁcation
of RNA from D78 and DK01 in bursa tissues,
and DK01 in lymphoid tissues and bursal swabs
indicated replication and excretion of very vir-
ulent ﬁeld virus from vaccinated chickens, sug-
gesting an explanation to previous ﬁeld out-
breaks in vaccinated ﬂocks. Further research
into the impact of stress factors inﬂuencing
dual IBDV infections under ﬁeld conditions is
in progress.
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Sammendrag
Fund af meget virulent IBD-virus hos vaccinerede
kyllinger.
Formålet med dette eksperiment var at undersøge,
om vaccinerede kyllinger kan have betydning for
tilstedeværelse og spredning af infectious bursal dis-
ease virus (IBDV) blandt kyllinger. To grupper speci-
ﬁkt patogen fri (SPF) kyllinger blev vaccineret med
den intermediære infectious bursal disease (IBD)
vaccine D78. Kyllingerne i gruppe 1 og 2 var hen-
holdsvis én og tre uger gamle ved vaccinationen. Fire
uger gamle blev begge grupper podet med meget vir-
ulent virus (DK01). En tredie gruppe, som kun blev
podet med vaccine virus, blev brugt som negativ kon-
trol. Kyllingerne blev aﬂivet og obduceret tre ad gan-
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kunne ikke påvises hverken kliniske symptomer eller
patologiske forandringer hos nogen af grupperne.
Lymfoidt væv fra bursa Fabricius, knoglemarv, milt
og thymus, samt bursa- og kloaksvabere blev under-
søgt ved one-step reverse transcription polymerase
chain reaction (RT-PCR). Positive resultater blev
bekræftet ved two-step duplex (DPX) RT-PCR. Vac-
cinestammen blev fundet i bursavæv fra alle grupper.
RNA fra DK01 blev fundet i en knoglemarvsprøve
fra gruppe 1 samt i tre bursa-prøver, en thymus og en
bursa svaber fra gruppe 2. Resultaterne tyder på, at
meget virulent IBD virus kan opformeres i og ud-
skilles fra vaccinerede kyllinger.
Detection of vvIBDV in vaccinated SPF chickens 227
Acta vet. scand. vol. 46 no. 4, 2005
(Received May 17, 2005; accepted July 31, 2005).
Reprints may be obtained from: Susanne Kabell, Danish Institute for Food and Veterinary Research, Hangøvej
2, DK-8200 Aarhus N. E-mail: ska@dfvf.dk, tel. +45 72 34 68 36, fax. +45 72 34 68 49.